SAVE Post-MI LV Dysfunction Prognostic Score (Proposed)

Clinical calculation support · Verify results before clinical use

Proposed point calculator

Enter the patient's clinical variables to calculate the experimental point total. All fields are required.

Unvalidated prototype

About this proposed score

This educational prototype sums eight variables that are clinically associated with prognosis after myocardial infarction: age, LVEF, Killip class, infarct location, diabetes, serum creatinine, systolic blood pressure, and heart rate.

How to interpret the output

The displayed total and point band reflect only the proposed rules encoded here. No validated equation, derivation cohort, calibration assessment, discrimination statistic, or external validation was identified for this exact score. Therefore, the output is a point tally—not a validated prediction of mortality or other outcomes.

Important limitations

  • The score weights and point-band cutoffs are proposed and have not been validated as a prognostic instrument.
  • The original SAVE trial evaluated captopril in selected post-MI patients with LVEF ≤40%; it did not establish this eight-variable point score.
  • Do not use this prototype as a substitute for validated risk tools, guideline-directed care, or clinician assessment.

Point assignment used

VariableProposed rulePoints
Age<55 / 55–64 / 65–74 / ≥75 y0 / 1 / 2 / 3
LVEF>40 / 31–40 / ≤30%0 / 2 / 4
Killip classI / II / III / IV0 / 1 / 2 / 4
Anterior MINo / Yes0 / 1
DiabetesNo / Yes0 / 1
Creatinine<1.5 / 1.5–2.0 / >2.0 mg/dL0 / 1 / 2
Systolic BP≥120 / 100–119 / 90–99 / <90 mmHg0 / 1 / 2 / 3
Heart rate<100 / 100–109 / ≥110 bpm0 / 1 / 2

These are preserved from the supplied source code for transparency, not endorsed as validated coefficients.

Scientific reference and evidence context

Pfeffer MA, Braunwald E, Moyé LA, et al.; the SAVE Investigators.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial.

N Engl J Med. 1992;327:669–677. doi:10.1056/NEJM199209033271001 · PMID: 1386652

The publication supports the historical context of the SAVE trial and the prognostic relevance of LV dysfunction after MI. It does not validate the proposed score implemented on this page.

Educational-use disclaimer: This calculator is an experimental educational prototype and is not intended for clinical decision-making. Its point assignments and risk bands have not been validated. Interpret patient risk using appropriate validated instruments, current guidelines, and the full clinical context.